Evofem Biosciences
EVFM
$0.01675
Share price
17.96%
Change (1 day)
-16.25%
Change (1 year)
Categories
Evofem Biosciences (EVFM) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $77.06 M
According to Evofem Biosciences 's latest financial reports the company's total liabilities are $77.06 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Evofem Biosciences - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $96.96 M | -31.76% |
| 2021-12-31 | $0.14 B | 30.81% |
| 2020-12-31 | $0.10 B | 758.05% |
| 2019-12-31 | $12.65 M | -53.74% |
| 2018-12-31 | $27.36 M | -73.59% |
| 2017-12-31 | $0.10 B | 11386.14% |
| 2016-12-31 | $0.9 M | -94.47% |
| 2015-12-31 | $16.3 M | 39.95% |
| 2014-12-31 | $11.65 M | 10.44% |
| 2013-12-31 | $10.54 M | 2% |
| 2012-12-31 | $10.34 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $0.62 B | 707.74% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $12.01 M | -84.41% | 🇺🇸 USA |